Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

110.53 -0.82 (-0.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,179,722
Open 111.35
Bid (Size) 108.80 (1)
Ask (Size) 110.51 (3)
Prev. Close 111.35
Today's Range 109.53 - 112.24
52wk Range 89.00 - 213.91
Shares Outstanding 146,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. 
Via InvestorPlace
Illumina Unusual Options Activity For May 07
Via Benzinga

Performance

YTD
-19.68%
-19.68%
1 Month
-15.74%
-15.74%
3 Month
-19.81%
-19.81%
6 Month
+12.36%
+12.36%
1 Year
-46.91%
-46.91%

More News

Read More
Beyond The Numbers: 6 Analysts Discuss Illumina Stock
Via Benzinga
Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens
Via Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Via Benzinga
Topics Stocks
Exposures US Equities
Looking Into Illumina's Recent Short Interest
Via Benzinga
Leading the Way: Swoop Named Provider of Choice for Employee Shuttling by Fortune 500 & Renowned Technology Companies
Via PRLog
ILMN Stock Earnings: Illumina Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
Via Benzinga
Topics Stocks
Exposures US Equities
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
Via InvestorPlace
Jim Cramer Rejects Illumina As 'It's Not Well-Run,' Recommends Buying This Tech Stock 'Right Here, Right Now'
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Cathie Wood Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving
Via InvestorPlace
Jim Cramer Isn't Going With This Tech Company: 'It's Complicated. I'm A Nvidia Guy'
Via Benzinga
Nasdaq’s Nosebleed Section: 3 Expensive Stocks to Sell Before It’s Too Late
Via InvestorPlace
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months
Via Talk Markets
Why Illumina Stock Zoomed Higher on Thursday
Via The Motley Fool
EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser
Via Benzinga
Icahn’s All-In: 3 Stocks Billionaire Carl Icahn Is Betting Big On
Via InvestorPlace
Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts
Via Benzinga
Earnings Crushers: Unveiling Q4’s 3 Top Stock Superstars
Via InvestorPlace
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
Via InvestorPlace
7 No-Frills Dividend Stocks for Your Must-Own List
Via InvestorPlace
Over $1M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Why Illumina Stock Mashed the Market on Monday
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.